UnitedHealth Group Incorporated (UNH)
UnitedHealth stock crashes to 4-year lows; Here's why
The already turbulent situation for UnitedHealth (NYSE: UNH) has only worsened with a deluge of adverse developments. The latest turmoil on Tuesday, May 13 ensured that UNH stock collapsed 10.17% in pre-market from its latest closing price of $378.75 to $340.25 at the time of publication.
UnitedHealth CEO abruptly quits, predecessor returns in major shakeup
Former CEO and current chairman Stephen Hemsley is stepping back into the top job following the abrupt resignation of Andrew Witty, UnitedHealth said.
UnitedHealth withdraws guidance and replaces CEO after rise in care activity in Medicare Advantage
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) shares fell over 10% in premarket trading after the health insurance giant withdrew its guidance for the current year and announced the departure of its chief executive officer. Stephen J.
UnitedHealth Group said Chairman Stephen Hemsley will return to running the healthcare giant he helped build, replacing Chief Executive Andrew Witty
Chairman Stephen Hemsley will return to running the healthcare giant he helped build, succeeding CEO Andrew Witty.
UnitedHealth Names New CEO and Suspends 2025 Outlook. The Stock Falls Sharply.
Stephen J. Hemsley will take over as chief executive replacing current CEO Andrew Witty.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UnitedHealth concealed how backlash from CEO Brian Thompson's killing was hurting profit: shareholder lawsuit
UnitedHealth shares fell 22% on April 17, wiping out about $119 billion of market value, after the insurer cut its 2025 forecast.
UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Report: UnitedHealth Has 1,000 AI Applications in Production
UnitedHealth Group is reportedly increasing its use of artificial intelligence across its business. The company has 1,000 AI applications in production, The Wall Street Journal reported Monday (May 5).
UnitedHealth Now Has 1,000 AI Use Cases, Including in Claims
But artificial intelligence on its own will never deny a claim, assures the insurer's chief digital and technology officer
UnitedHealth Group: It's Time To Be Greedy While The Market Panics
Avoid stocks priced for 'best case scenario'; seek those priced for 'worst case scenario' for potential substantial upside, like UNH. UNH's 25% decline due to temporary issues presents a buying opportunity with strong long-term earnings growth and high dividend yield. UNH's fundamentals remain strong despite recent setbacks; management projects a return to 13-16% earnings growth and high dividend growth.
UnitedHealth Group: Mr. Market Has Got It All Wrong
UnitedHealth's stock tanked following the Q1 earnings report after the company revised the earnings guidance for this year. Upon closer evaluation, it is evident that the challenges faced by the company are likely to be short-lived. The company is cheaply valued from a historical perspective, which does not make a lot of sense given strong growth expectations for the next five years.
